Appendicitis: Knowing Your Options
Did you know antibiotics are a treatment option for uncomplicated appendicitis? A new survey revealed patient preferences on this and other appendicitis treatment options.
FDA Issues Warning for Liver Rx
The US Food and Drug Administration (FDA) is warning that a medication for a rare liver disease could pose deadly risks to some patients.
Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Who Should Really Go Gluten-Free
Going gluten-free may not be healthy for everyone.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Biologics Show Promise for Bowels
Biologic treatments for inflammatory bowel diseases may help heal the intestines, a new study found.
FDA Warns About IBS Rx Complication
If you've had your gallbladder removed, the US Food and Drug Administration (FDA) is warning that you shouldn't use a particular irritable bowel syndrome medication.
Why the Hepatitis C 'Cure' Rate Spiked
Hepatitis C "cure" rates increased 21-fold between 2010 and 2015, a new study found. That increase is likely due to a transformation in the available treatments.
Hep C, Baby Boomers and Testing
In 2015, nearly 86 percent of baby boomers had never been screened for the hepatitis C virus (HCV), a new study found. And that may put them at unnecessary risk for liver disease.
A New Treatment for Chronic Constipation
The US Food and Drug Administration has approved a new treatment option for chronic constipation.